by Georgia Brewer, HEAL California, September 2, 2016

The panic over skyrocketing drug prices is growing exponentially. When it was mainly patients with rare diseases facing obscene price hikes for medicine, many Americans gritted their teeth and looked away, grateful it wasn’t their problem. But now “trickle down” has a new meaning. More and more of us (including children) who have fairly common ailments like diabetes and allergies are suddenly discovering we cannot afford the medicines we depend on to live. The outrageous mess with Mylan Pharmaceuticals’ EpiPen is only the most recent, glaring example, but the prices of insulin, Gleevac, Solvaldi and others are exploding too. “Big Business Picking Our Pockets” Per Michael Winship, senior writer for, in his article Drugs and Privilege: Big Business, Congress and the EpiPen (Nation of Change, 8/31/16): “…this is one more, big old scam — yet another case of big business trying to pull the wool over […] Read More